Nestlé Purina’s $1 Million Grant to Revolutionize Urinary Health for Pets – Here’s What It Means for Your Clients!
Nestlé Purina PetCare has granted $1 million to support the G.V. Ling Urinary Stone Analysis Laboratory at the School of Veterinary Medicine. Over five years, the grant will enable veterinarians to provide free urinary stone analyses for pets, helping researchers explore new diets, treatments, and technologies for managing urinary diseases in companion animals. Learn more about this groundbreaking initiative and its potential impact on pet health.
Join the Walk to Save Pets! Community Veterinary Outreach Celebrates 21 Years with Nationwide Fundraising Challenge
Community Veterinary Outreach (CVO) celebrates 21 years of providing veterinary and human healthcare to pets and people in need across Canada. This fall, CVO is hosting the second annual Cross-Canada Community Challenge from October 1-31, 2024, to raise $100,000 to meet growing demand for care. Participants will log their activities to symbolically walk across Canada, with giveaways, prizes, and a speaker series featuring top veterinary experts. Learn how you can join the cause and support pets and their owners in need.
Revolutionary AI-Powered Blood Analyser by Zoetis to Debut at London Vet Show – See How It’s Changing Veterinary Diagnostics!
Zoetis will unveil its new AI-powered haematology analyser, Vetscan OptiCell™, at the London Vet Show on November 14-15, 2024. This cartridge-based analyser offers reference lab-quality CBC analysis at the point of care, providing significant time, cost, and space savings for veterinary teams. Learn how this innovative tool is set to redefine veterinary diagnostics and improve patient care.
Elanco Launches Zenrelia™, a JAK Inhibitor for Dogs with Allergic and Atopic Dermatitis
Elanco has received FDA approval for Zenrelia™, a once-daily oral JAK inhibitor for treating pruritus and atopic dermatitis in dogs. Zenrelia offers superior results compared to Apoquel®, with 77% of dogs achieving clinical remission of itch. This groundbreaking solution will ship soon in the U.S., revolutionizing care for millions of itchy dogs. Learn more about Zenrelia’s benefits and how it’s changing the game in canine dermatology.
FDA Approves New Treatment for Allergic Skin Conditions in Dogs
Today, the U.S. Food and Drug Administration approved Zenrelia (ilunocitinib tablets), a new animal drug used to control pruritus (itching) associated with allergic dermatitis and to control atopic dermatitis (environmental allergies) in dogs at least 1 year of age.
Global Symposium to Focus on the Gut Microbiome-Organ Connection for Improved Pet Health
Hill's Pet Nutrition has announced that the 2024 Hill’s Global Symposium will focus on the connection between the gut microbiome and organ health, presenting one of the largest global educational opportunities for veterinary professionals. This year’s theme, "Nourish the Gut, Nurture the Future," builds on Hill’s decade-long research into microbiome health, offering a platform for top experts to share insights on how the gut microbiome plays a pivotal role in advancing pet health care. The event will provide practical applications to enhance clinical decision-making and improve overall pet health.